• Sponsored Content

A Transient Cell Line To Produce rAAV With Low-level hcDNA Encapsidation

BPI Contributor

May 16, 2024

1 Min Read
Cytiva transient cell line

The landscape of recombinant adeno-associated virus (rAAV) manufacturing is witnessing a transformative shift, where stable producer cell lines are emerging as the cell factories of the future. However, the move towards producer cell lines is a nuanced journey, requiring the use of transient transfection cell lines where flexibility and speed are of essence.

To address these needs, we developed a novel human embryonic kidney (HEK) 293 suspension cell line, the ELEVECTA™ transient cell line, designed to seamlessly integrate into various research workflows or large-scale GMP production. Here we demonstrate its capability for efficient and scalable production of rAAVs across multiple serotypes with low levels of encapsidated host cell DNA (hcDNA).

You May Also Like